Evaluation of a Post-Marketing Safety Signal Associated with a Novel Innovative Medicinal Product and Coordination with Regulatory Authorities

Ivana Mitrevska, Zorica Naumovska, Trajce Mitrev, Olivera Paneva

Open source

DOI
10.20944/preprints202605.1030.v1
Published
2026-05-15
Container
Not recorded
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20944/preprints202605.1030.v1,
  title = {Evaluation of a Post-Marketing Safety Signal Associated with a Novel Innovative Medicinal Product and Coordination with Regulatory Authorities},
  author = {Ivana Mitrevska and Zorica Naumovska and Trajce Mitrev and Olivera Paneva},
  year = {2026},
  doi = {10.20944/preprints202605.1030.v1},
  url = {https://doi.org/10.20944/preprints202605.1030.v1}
}

RIS

TY  - JOUR
TI  - Evaluation of a Post-Marketing Safety Signal Associated with a Novel Innovative Medicinal Product and Coordination with Regulatory Authorities
AU  - Ivana Mitrevska
AU  - Zorica Naumovska
AU  - Trajce Mitrev
AU  - Olivera Paneva
PY  - 2026
DO  - 10.20944/preprints202605.1030.v1
UR  - https://doi.org/10.20944/preprints202605.1030.v1
ER  - 

APA

Mitrevska, I., Naumovska, Z., Mitrev, T., & Paneva, O. (2026). Evaluation of a Post-Marketing Safety Signal Associated with a Novel Innovative Medicinal Product and Coordination with Regulatory Authorities. https://doi.org/10.20944/preprints202605.1030.v1

Source records